A holistic approach to targeting disease with polymeric nanoparticles
Open accessThe DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Abstract
The primary goal of nanomedicine is to improve clinical outcomes. To this end, targeted nanoparticles are engineered to reduce non-productive distribution while improving diagnostic and therapeutic efficacy. Paradoxically, as this field has matured, the notion of targeting has been minimized to the concept of increasing the affinity of a nanoparticle for its target. This Opinion article outlines a holistic view of nanoparticle targeting, in which the route of administration, molecular characteristics and temporal control of the nanoparticles are potential design variables that must be considered simultaneously. This comprehensive vision for nanoparticle targeting will facilitate the integration of nanomedicines into clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Encapsulation of hepcidin into biocompatible nanocarriers suitable for controlled release of therapeutics (Cheng et al., 2015) could theoretically address this issue.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Cheng et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Research works printed but not linked: 5
- Bertrand N Leroux JC The journey of a drug-carrier in the body: an anatomo-physiological perspective Journal of Controlled Release: Official Journal of the Controlled Release Society 161 152 163 2012 22001607
- Davis ME Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 1067 U140 2010 20305636 PMC2855406
- Wang YC Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury Biomaterials 29 4546 4553 2008 18774604
- Kaur IP Kakkar S Nanotherapy for posterior eye diseases Journal of Controlled Release: Official Journal of the Controlled Release Society 2014 24862316
- Li H A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 83 824 833 2006 16822505
Cited by
Items 301–400 of 492
Polymeric and Ceramic Nanoparticles: Possible Role in Biomedical Applications
Kaushik, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-40513-7_39 · Cited by 15
Shipunova, V. O., Nikitin, M. P., Zelepukin, I. V., Nikitin, P. I., Deyev, S. M., & Petrov, R. V. (2015) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672915050117 · Cited by 15
Development of hematin conjugated PLGA nanoparticle for selective cancer targeting
Amin, M. L., Kim, D., & Kim, S. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.05.029 · Cited by 15
Ahmed, S., Mujahid, M. H., Kour, M., Fatima, S., Ahamad, S., Mishra, S. K., Bhat, A. R., Abu‐Rayyan, A., & Tebeje, B. A. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103459 · Cited by 14
Nasab, A. S., Banafshe, H. R., Atapour, A., Mahabady, M. K., Akbari, M., Daraei, A., Mansoori, Y., & Hasan‐Abad, A. M. (2024) · Frontiers in Medical Technology · doi:10.3389/fmedt.2023.1330007 · Cited by 16
Austria, E. S., Jr., & Akhavan, B. (2025) · Nanoscale · doi:10.1039/d5nr00436e · Cited by 14
Dual pH-Responsive Polymer Nanogels with a Core–Shell Structure for Improved Cell Association
Sui, H., Gao, Z., Guo, J., Wang, Y., Yuan, J., Hao, J., Dong, S., & Cui, J. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b03107 · Cited by 14
Addison, M., Ranasinghe, P. D., & Webb, D. J. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2277330 · Cited by 16
Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions
Man, H. S. J., Moosa, V. A., Singh, A. N., Wu, L., Granton, J. T., Juvet, S., Hoang, C. D., & de Perrot, M. E. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1281538 · Cited by 15
Fan, Z., Liu, G., Li, Y., Ma, J., Lin, J., Guo, F., Hou, Z., & Xie, L. (2016) · RSC Advances · doi:10.1039/c6ra17714j · Cited by 15
Nanogene editing drug delivery systems in the treatment of liver fibrosis
Wang, Q., Jia, S., Wang, Z., Chen, H., Jiang, X., Li, Y., & Ji, P. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1418786 · Cited by 13
Physicochemical and Surface Properties of Nanoparticles: Effects on Cellular Pathway and Uptake
Zhang, J., Liu, R., Yang, Z., Luo, C., Chen, J., Guo, B., Weitz, D. A., & Chen, D. (2025) · ChemNanoMat · doi:10.1002/cnma.202500043 · Cited by 13
Khosravi, F., Rahmani, P., & Jahanban‐Esfahlan, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118551 · Cited by 16
Braunger, J. A., Björnmalm, M., Isles, N. A., Cui, J., Henderson, T. M. A., O’Connor, A. J., & Caruso, F. (2016) · Biomaterials Science · doi:10.1039/c6bm00726k · Cited by 13
Wu, M., Guo, Q., Xu, F., Liu, S., Lu, X., Wang, J., Gao, H., & Luo, P. (2016) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2016.05.023 · Cited by 13
Kulhari, H., Telukutla, S. R., Pooja, D., Shukla, R., Sistla, R., Bansal, V., & Adams, D. J. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0067 · Cited by 13
Microfluidic production of inorganic nanomaterials for biomedical applications
Sebastián, V., & Arruebo, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812659-2.00008-9 · Cited by 13
How should we plan the future of nanomedicine for cancer diagnosis and therapy?
Alhareth, K., Sancey, L., Tsapis, N., & Mignet, N. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.037 · Cited by 13
Targeted gene delivery systems for T-cell engineering
Wang, F., Huang, Y., Li, J., Zhou, W., & Wang, W. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00954-6 · Cited by 13
Targeting Polymeric Nanoparticles to Specific Cell Populations in the Liver
Harkins, L., Vilarinho, S., & Saltzman, W. M. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00712 · Cited by 12
Self-citationMarandi, M., Safary, A., Abdolahinia, E. D., Fathi, M., Barar, J., & Omidi, Y. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114739 · Cited by 12
Sahlabadi, M., Daryanavard, M., Hadadzadeh, H., & Amirghofran, Z. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.11.029 · Cited by 12
Multifunctional Patented Nanotherapeutics for Cancer Intervention: 2010- Onwards
Pandey, P., Chopra, H., Kaushik, D. K., Verma, R., Purohit, D., Parashar, J., Mittal, V., Rahman, M. H., Bhatia, S., Kumar, P., et al. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892817666220322085942 · Cited by 12
Engineering Platforms for T Cell Modulation
Hickey, J. W., Kosmides, A. K., & Schneck, J. P. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.06.003 · Cited by 17
Biodegradable Inorganic Nanovector: Passive versus Active Tumor Targeting in siRNA Transportation
Park, D., Cho, J., Kwon, O., Yun, C., & Choy, J. (2016) · Angewandte Chemie · doi:10.1002/ange.201510844 · Cited by 12
Polymer nanocarriers for targeted local delivery of agents in treating brain tumors
Josowitz, A. D., Bindra, R. S., & Saltzman, W. M. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac9683 · Cited by 12
Self-citationDouble-headed nanosystems for oral drug delivery
Kaur, G., Arora, M., Ganugula, R., & Kumar, M. N. V. R. (2019) · Chemical Communications · doi:10.1039/c8cc10021g · Cited by 12
Ahmad, A., Ansari, M. M., Alasmari, A. F., Ali, N., Maqbool, M. T., Raza, S. S., & Khan, R. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.10.028 · Cited by 11
Shah, D., Bhattacharya, S., Gupta, G. L., Hatware, K. V., Jain, A., Manthalkar, L., Phatak, N., & Sreelaya, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25172 · Cited by 11
Lee, A.-R., Baek, S.-M., Lee, S.-W., Kim, T., Han, J. E., Bae, S., Park, S., Kim, T., Jeong, K., Choi, S., et al. (2021) · In Vivo · doi:10.21873/invivo.12400 · Cited by 13
Xu, G., Tang, H., Chen, J., Zhu, M. J., Xie, Y., Li, Y., Hao, Q., Sun, Y., Cong, D., Meng, Q., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105780 · Cited by 11
Targeting Biological Barriers: Turning a Wall into a Therapeutic Springboard
Moghimi, S. M., & Howard, K. A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.03.008 · Cited by 11
Biological and Bioinspired Vesicles for Wound Healing: Insights, Advances and Challenges
Zhao, Y., Zhang, T., Zhao, G., Lu, J., Zhang, X., Lai, Y., Chen, Z., Ding, X., & Tai, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s522067 · Cited by 12
Thulasimuthu, E., Veeramani, S., & Ilangovan, R. (2024) · BioNanoScience · doi:10.1007/s12668-024-01644-1 · Cited by 10
Nanomaterials, Autophagy, and Lupus Disease
Bianco, A., & Muller, S. (2015) · ChemMedChem · doi:10.1002/cmdc.201500233 · Cited by 10
Inflammation-Responsive Polymers
Espinosa‐Cano, E., Aguilar, M. R., Vázquez‐Lasa, B., & Román, J. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102416-4.00007-7 · Cited by 13
Batch and microfluidic reactors in the synthesis of enteric drug carriers
Arruebo, M., & Sebastián, V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818038-9.00008-9 · Cited by 12
Quinlan, J. A., Baumiller, K., Gaur, A., Chiou, W., Robey, R. W., Gottesman, M. M., & Huang, H. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202400098 · Cited by 9
HPMA nanomedicine: targeting cancer with precision
Rani, S., Kumar, V., Tarannum, S., & Gupta, U. D. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02341b · Cited by 9
Chen, X., Yang, X., Chen, X., Cheng, Y., & Li, Z. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126031 · Cited by 9
Liu, X., Wang, W., Li, Q., Niu, H., & Zhang, W. (2024) · International Journal of Smart and Nano Materials · doi:10.1080/19475411.2024.2395270 · Cited by 9
Targeted polyethylenimine/(p53 plasmid) nanocomplexes for potential antitumor applications
Zhong, Y., Wang, Y., Luo, L., Nurhidayah, D., Maruf, A., Gregersen, H. N., Wu, W., & Wang, G.-X. (2018) · Nanotechnology · doi:10.1088/1361-6528/aaf41a · Cited by 9
Potential of Chitosans in the Development of Edible Food Packaging
Coma, V., & Bartkowiak, A. (2019) · Wiley eBooks · doi:10.1002/9781119450467.ch14 · Cited by 9
Spatiotemporal precision interventions for cardiac repair and regenerative therapy
Ting, M. H., Zhang, H., Liu, S., Wang, P., Li, H., Zhang, W., Ge, J., & Zhang, N. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01704-4 · Cited by 9
Encapsulating In Vitro Transcribed circRNA into Lipid Nanoparticles Via Microfluidic Mixing
Juchem, M., Cushman, S., Lu, D., Chatterjee, S., Bär, C., & Thum, T. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3678-7_14 · Cited by 8
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities
Diwan, R., Gaytan, S. L., Bhatt, H. N., Pena‐Zacarias, J., & Nurunnabi, M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01551-8 · Cited by 8
Supramolecular Polymers in Nanomedicine
Homyak, C., Anson, F., & Thayumanavan, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12566-1 · Cited by 9
Biodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery
Kempe, K., & Nicolazzo, J. A. (2020) · Neuromethods · doi:10.1007/978-1-0716-0838-8_1 · Cited by 10
Polymeric nanomaterials with aggregation-induced emission characteristics
Gao, F., Wei, W.-C., Xu, Y., Zhao, Z., Qiu, Z., & Tang, B. Z. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00562c · Cited by 8
Gupta, U., Maity, D., & Sharma, V. K. (2023) · Biomedical Materials · doi:10.1088/1748-605x/ad0b23 · Cited by 9
Heuristics for the Optimal Presentation of Bioactive Peptides on Polypeptide Micelles
Wang, J., Saha, S., Schaal, J. L., Yousefpour, P., Li, X., & Chilkoti, A. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03141 · Cited by 8
Polymer nanoparticle drug-nucleic acid combinations
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00014-7 · Cited by 11
AR independent anticancer potential of enza against prostate cancer
Baker, A., Syed, A., Iram, S., Elgorban, A. M., Al-Harthi, H. F., Al-Rejaie, S. S., Kim, J., & Khan, M. S. (2022) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2022.128598 · Cited by 8
Advanced Polymeric Nanotechnology to Augment Therapeutic Delivery and Disease Diagnosis
Martins, C., Chauhan, V. M., Araújo, M., Abouselo, A., Barrias, C. C., Aylott, J. W., & Sarmento, B. F. C. C. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0145 · Cited by 8
Innovative Polymers for Controlled Release Applications
Zhong, Z. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01459 · Cited by 8
RECENT ADVANCES IN NANOCARRIERS FOR TARGETED CANCER THERAPY
Dandekar, M. R., Telrandhe, U. B., Salve, Y. M., & Mirzapure, I. A. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i6.54347 · Cited by 9
Inflammation-specific DNA origami nanodevice for delivery of siRNAs to treat ulcerative colitis
Zhang, T., Li, R., Wang, Z., Zhou, Y. H., Zhou, Y., Chen, X., Cui, P., Jiang, Y., Tong, N., & Li, W. (2025) · Nature Communications · doi:10.1038/s41467-025-67183-9 · Cited by 7
Bains, B. K., Greene, M. K., McGirr, L. M., DORMAN, J. H., Farrow, S. N., & Scott, C. J. (2016) · Journal of Interdisciplinary Nanomedicine · doi:10.1002/jin2.9 · Cited by 7
Nanomaterials in Cancer Theranostics
Zhu, L., Yang, L. P. H., & Zhou, Z. (2017) · Nanomedicine and nanotoxicology · doi:10.1007/978-981-10-5864-6_8 · Cited by 8
Drug Delivery Systems Based on Polymeric Blend: A Review
Abass, K. H., Kadim, A. M., Mohammed, S. K., & Agam, M. A. (2021) · Nano Biomedicine and Engineering · doi:10.5101/nbe.v13i4.p414-424 · Cited by 7
The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions
Sharma, I., Bhardwaj, S., Karwasra, R., Kaushik, D., & Sharma, S. (2023) · Recent Patents on Nanotechnology · doi:10.2174/1872210517666230721123453 · Cited by 7
Pal, I., Illendula, A., Joyner, A., Manavalan, J. S., Deddens, T. M., Sabzevari, A., Damera, D. P., Zuberi, S., Marchi, E., Fox, T. E., et al. (2025) · Blood · doi:10.1182/blood.2024027997 · Cited by 7
Nanotechnology in pulmonary tissue engineering
Virmani, R., Sharma, A., Sharma, A., Kumar, G., Virmani, T., & Mukherjee, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95134-0.00017-1 · Cited by 9
Molecular Imaging of Brain Tumors Using Liposomal Contrast Agents and Nanoparticles
Mehta, A., Ghaghada, K. B., & Mukundan, S. (2016) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2016.06.004 · Cited by 7
Erratum: A holistic approach to targeting disease with polymeric nanoparticles
Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4633 · Cited by 7
Self-citationTietjen, G. T., DiRito, J. R., Pober, J. S., & Saltzman, W. M. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.003 · Cited by 6
Self-citationCortivo, G. D., Wagner, G. E., Cortelletti, P., Das, K. M., Zangger, K., Speghini, A., Dell’Orco, D., & Meyer, N. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-21571-y · Cited by 6
Drug Disposition Considerations in Pharmaceutical Product
Maheshwari, R., Sharma, P. A., Seth, A., Taneja, N., Tekade, M., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814423-7.00010-1 · Cited by 12
Ding, Z., Zhang, X., Wang, Y., Ogino, K., Wu, Y., Yue, H., Jiao, Z., Cui, S., Lu, G., Wang, S., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101815 · Cited by 6
Crystalsomes via confined polymer crystallization in nanoemulsions
Yu, S., Furner, C. T., Esmati, N., & Li, C. Y. (2025) · Polymer · doi:10.1016/j.polymer.2025.128054 · Cited by 9
Active targeting of CD4 + T lymphocytes by PEI-capped, peptide-functionalized gold nanoparticles
Ncobeni, N., de la Torre, B. G., Alberício, F., Kruger, H. G., & Parboosing, R. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac7885 · Cited by 6
Nano-BTA: A New Strategy for Intravesical Delivery of Botulinum Toxin A
Liu, Q., & Liao, L. (2022) · International Neurourology Journal · doi:10.5213/inj.2142124.062 · Cited by 6
Nanomaterials in tissue engineering: Applications and challenges
Upadhyay, L. S. B., Rana, S., & Kumar, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88450-1.00018-1 · Cited by 9
Heo, H. J., Park, Y., Lee, J. H., Kim, Y., Kim, E. K., Kim, G. H., Yu, Y., Park, S. Y., Seo, H. B., Pak, K., et al. (2022) · Nanoscale · doi:10.1039/d2nr04238j · Cited by 6
Espinosa‐Cano, E., Aguilar, M. R., Portilla, Y., Barber, D. F., & Román, J. S. (2020) · Macromolecular Bioscience · doi:10.1002/mabi.202000002 · Cited by 6
Stimuli‐Responsive Nanomaterials for Smart Tumor‐Specific Phototherapeutics
Zhou, B., Guo, Z., Lin, Z., Jiang, B., & Shen, X. (2020) · ChemMedChem · doi:10.1002/cmdc.202000831 · Cited by 6
Bridging cancer therapies: the role of magnetic nanoparticles in combination cancer therapy
Damavandi, S. E., Jozdani, S. M. B., Elyasigorji, Z., & Vosough, M. (2026) · Discover Nano · doi:10.1186/s11671-026-04439-3 · Cited by 5
Mohanrasu, K., Prakash, G. S., Thulasinathan, B., Veleeswaran, A., Dinesh, G. H., Anand, K., Muniyasamy, S., Chuturgoon, A. A., & Arun, A. (2020) · Engineering materials · doi:10.1007/978-3-030-36260-7_6 · Cited by 6
de Souza, F. G., de Lima, N. R. B., Roullin, G., Pal, K., & da Silva, N. D. (2021) · Current Radiopharmaceuticals · doi:10.2174/1874471014999210128183231 · Cited by 6
Ren, L. F., Kim, Y. J., Park, S. Y., Lee, S., Lee, J., Park, C. P., & Lim, Y. T. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00935b · Cited by 5
Commercial Aspects of Vaccine Development
Halliday, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39981-4.00022-1 · Cited by 5
Novel Approaches of Nanotechnology in Agro and Food Processing
Kadam, D. M., & Kaur, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813351-4.00017-1 · Cited by 6
Nanosystems and antibacterial applications
Valappil, S. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50922-0.00005-5 · Cited by 6
Polymeric Micelles Employing Platinum(II) Linker for the Delivery of the Kinase Inhibitor Dactolisib
Shi, H., Lou, B., van Steenbergen, M. J., Sijbrandi, N. J., Hennink, W. E., & Kok, R. J. (2019) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201900236 · Cited by 5
Polymeric and Ceramic Nanoparticles: Possible Role in Biomedical Applications
Kaushik, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-10614-0_39-1 · Cited by 5
Olvera‐Guillen, R., Juárez‐Moreno, K., Cruz-Soto, M. E., Rocha‐Botello, G., & Herrera‐Ordóñez, J. (2021) · Journal of Nanoparticle Research · doi:10.1007/s11051-021-05241-1 · Cited by 6
Haque, M. R., Rana, M. M., Akhtar, N., Rahman, M. S., & Asaduzzaman, S. M. (2024) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/s43578-024-01380-y · Cited by 4
A Comprehensive Review on Polycaprolactone: A Promising Polymer for Enhancing Drug Bioavailability
Dubey, S., Patel, S., Pradhan, M., Yadav, D. K., & Minz, S. (2025) · Polymer-Plastics Technology and Materials · doi:10.1080/25740881.2025.2499826 · Cited by 4
Smart Nanovesicles for Drug Targeting and Delivery
Carafa, M., & Marianecci, C. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-895-4 · Cited by 4
Wanted: An endothelial cell targeting atlas for nanotherapeutic delivery in allograft organs
Liburd, S. T., Shi, A. A., Pober, J. S., & Tietjen, G. T. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17050 · Cited by 4
Self-citationRecent Advances in the Development of Membrane-derived Vesicles for Cancer Immunotherapy
Xiao, Y., Wu, M., Xue, C., & Wang, Y. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230504120841 · Cited by 4
Physiological Determinants and Plausible ‘6R’ Roadmap for Clinical Success of Nanomedicines
Shahiwala, A. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0114 · Cited by 4
Sakr, T. M., Morsy, S. A. G. Z., Mahmoud, N. A. M., Rashed, H. M., El‐Rehim, H. A. A., Khoobchandani, M., Katti, K. K., & Katti, K. V. (2018) · Preprints.org · doi:10.20944/preprints201808.0331.v1 · Cited by 5
Chaturvedi, A., Pranjali, P., Raj, R., Shukla, A., Singh, R., Tripathi, D. K., Poluri, K. M., Singh, R. K., Kumar, D., & Guleria, A. (2024) · Physica Scripta · doi:10.1088/1402-4896/ad8cb1 · Cited by 3
Huang, H., Xuan, Y., & Ma, Z.-C. (2025) · Nanotechnology Science and Applications · doi:10.2147/nsa.s500407 · Cited by 4
Shen, S., He, J., Song, S., Jiang, C., Li, J., Peng, S., Shen, C., & Zou, Q. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167028 · Cited by 4
Austria, E. S., Jr., Haidar, L. L., Nootem, J., New, E. J., Zhianmanesh, M., Zhao, H. Y., Zheng, Z., Liu, Z., Fraser, S. T., Alavi, S. K., et al. (2025) · Advanced Materials Interfaces · doi:10.1002/admi.202500322 · Cited by 3
Zhu, X., Sun, H., Cao, X., & Xia, J. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105448 · Cited by 4
The Role of “Missile” and “Targeting” Metaphors in Nanomedicine
Oftedal, G. (2019) · Philosophia Scientae · doi:10.4000/philosophiascientiae.1742 · Cited by 3
Nanobots in Cancer: a Short Review
Edem, S., Rajput, D., & Gupta, A. (2023) · Indian Journal of Surgery · doi:10.1007/s12262-023-03930-w · Cited by 3
Metadata
- Authors
- Cheng, C. J., Tietjen, G. T., Saucier-Sawyer, J. K., & Saltzman, W. M.
- Affiliations
- Yale University (US)
- Corresponding author
- Saltzman, W. Mark
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-01-19
- Volume
- 14
- Issue
- 4
- Pages
- 239-247
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC4451203
- OpenAlex
- W2041271505
- Cited by
- 480
- References
- 135
- Citations by year
- 2026: 13 · 2025: 37 · 2024: 31 · 2023: 41 · 2022: 42 · 2021: 37 · 2020: 42 · 2019: 40 · 2018: 46 · 2017: 63 · 2016: 60 · 2015: 27
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-04-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007974)
- National Cancer Institute (R01CA149128, F32CA174247, CA149128)
- National Institute of Allergy and Infectious Diseases (R01AI112443, T32AI089704, AI106992, R56AI106922, AI112443)
- National Institute of Biomedical Imaging and Bioengineering (EB00487, R01EB000487)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- targeted drug delivery, polymeric nanoparticles, nanomedicine, nanoparticle targeting, route of administration, nanoparticle design, clinical translation
- MeSH terms
- Animals, Humans, Polymers, Drug Delivery Systems, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.